419
-1.64%
Close of 9 Nov 2026, in JPY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About JMS Co
Its shares trade on Tokyo Stock Exchange under the ticker 7702.T. It has been listed since 1 December 1981. In the fiscal year to 31 March 2026, it reported revenue of ¥65.84bn and a net loss of ¥784.0m. At that date it held total assets of ¥83.07bn and shareholders' equity of ¥41.73bn.
JMS Co., Ltd. engages in the manufacture, sale, export, and import of medical devices and pharmaceuticals. The company is headquartered in Hiroshima, Hiroshima-Ken. is a Japan-based company mainly engaged in the manufacture and sale of medical equipment and drugs. The firm operates through five geographical segments including Japan, Singapore, China, Philippines and Germany. The firm is engaged in the manufacture and sale of infusion and nutrition products, dialysis products, surgery products, blood and cell products and other products. The Company’s main products include infusion & transfusion set, syringe pump, surgical gown, dialysis kit, peritoneal dialysate, microcatheter, blood bag, among others. The firm is also involved in the provision of maintenance service and other related services.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 1 Dec 1981
- Employees
- 5,650
- Website
- jms.cc ↗
Leadership
Pay as last reported
- Mr. Hiroaki OkukuboChairman of the Board, since 2003
- Mr. Ryuji KatsuraPresident, Representative Director, since 2011
- Mr. Yasuhiro AwaneVice President, Chief Director of Sales, Director, since 2011
- Mr. Toru SakodaChief Director of Global Marketing, Director, since 2023
- Mr. Jo SuedaExecutive Officer, Director of Human Resource in Main Corporate Unit, Chief Director of Corporate
- Mr. Eiji BanshoyaExecutive Officer, Senior Director of Surgical and Sales Business Unit
- Mr. Hideyuki KadohiroExecutive Officer, Senior Director of Hospital Products Business Unit Promotion, since 2023
- Mr. Mamoru NakamuraExecutive Officer, Miyoshi Plant Manager in Main Production Unit, Director of Production and Administration in Main Production Unit
- Mr. Raita UematsuChief Director of Research and Development, Director, since 2019
- Mr. Shogo YanagidaChief Director of Production, Izumo Plant Manager in Main Production Unit, Director, since 2013
- Mr. Yoshio KondoDirector, since 2011
- Mr. Kazuo IkemuraIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- JMS Co Ltd operates through five geographical segments including Japan, Singapore, China, Philippines, and Germany.
- The company manufactures and sells medical devices such as infusion & transfusion sets and dialysis kits.
- JMS Co Ltd has a strong employee base with 5,650 full-time employees.
Weaknesses
- JMS Co Ltd's IPO occurred in December 1981, indicating a long-standing presence but limited recent market activity.
- The company's operations are concentrated in the Health Care sector, limiting diversification.
- JMS Co Ltd is headquartered in Hiroshima, Japan, which may restrict access to global markets.
Opportunities
- Expanding into new geographical segments beyond Japan, Singapore, China, Philippines, and Germany could increase market reach.
- Growing demand for medical devices like infusion & transfusion sets and dialysis kits presents expansion opportunities.
- The company can leverage its 5,650 full-time employees to develop new products in the Health Care sector.
Threats
- Competition from other medical device manufacturers in the Health Care sector could impact market share.
- Regulatory changes in Japan and other countries may affect the manufacturing and sale of medical devices.
- Economic downturns in key markets like China and Germany could reduce demand for medical equipment.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.